## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `article_bundle` — **LLM article bundle** Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. - **article slug:** `pt-141-muscle-loss` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system. - **read:** https://miscsubjects.com/api/articles/pt-141-muscle-loss/bundle?format=markdown ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-muscle-loss/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-muscle-loss/topology - **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/pt-141-muscle-loss/voxels - **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-muscle-loss/prompts - **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node. - **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/pt-141-muscle-loss/voxels - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.* --- # miscsubjects article bundle > Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest. ## MASTHEAD - **identity:** `pt-141-muscle-loss` v2 · content_hash `2cd99cab024cedd1…` · thread_head genesis · 26 DIVs - **thesis (c1):** No scientific evidence or clinical research proves PT-141 increases muscle mass. - c2 [human/active] RECONNECT phase 3 trials showed statistically significant improvements in sexual desire and reduced distress versus placebo in women with HSDD. - c3 [mechanistic/active] PT-141 does not target muscle tissue regulatory processes for hypertrophy. - **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes - **standing objections:** 0 open → https://miscsubjects.com/api/articles/pt-141-muscle-loss/discourse - **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key - **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/pt-141-muscle-loss/discourse · https://miscsubjects.com/api/protocol ## Article - **slug:** `pt-141-muscle-loss` - **title:** PT-141 for Muscle Loss: Evidence Review - **url:** https://miscsubjects.com/a/pt-141-muscle-loss - **register:** source_ledger - **updated:** 2026-07-17T02:41:07.807Z - **tags:** peptide, matrix ## Body ## What's breaking down Muscle loss, or sarcopenia in clinical terms, involves progressive decline in muscle mass, strength, and function. This happens when protein breakdown outpaces repair in muscle tissue. Layers include reduced anabolic signaling, inflammation, hormonal shifts, inactivity, and neural drive changes. Over time, fewer motor units fire effectively and satellite cells repair less efficiently. The result is frailty and reduced physical capacity. No direct peptide catalog entry replaces addressing these layers through established means. ## Why PT-141 might help you PT-141 acts primarily on melanocortin receptors in the central nervous system to influence arousal pathways. The peptide chain focuses on the sexual / CNS arousal layer. 1. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain. If reduced sexual activity or CNS drive contributes to lower overall movement and muscle maintenance, some discuss PT-141 in that context. This remains indirect. No data show direct effects on muscle protein synthesis or satellite cell activity. Any potential link would sit at the speculative tier for muscle loss specifically. ## How these fit together Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile. - **PT-141** → sexual / CNS arousal This section maps layers without repetition. PT-141 addresses one narrow pathway. Other compounds would address separate degeneration layers if present. ## What the evidence actually shows Human trials of PT-141 (bremelanotide) center on hypoactive sexual desire disorder and erectile dysfunction. Phase 3 RECONNECT trials (two identical randomized, double-blind, placebo-controlled studies) enrolled premenopausal women and showed statistically significant gains in desire scores and reductions in distress versus placebo (human tier). No endpoints measured muscle mass, strength, or sarcopenia markers (human tier for sexual outcomes; absent for muscle). Preclinical data are limited to melanocortin effects in animal models of sexual function, with no published rat or mouse studies on muscle wasting or hypertrophy (preclinical tier: none identified for muscle loss). Anecdotal reports on forums mention libido changes but contain no consistent descriptions of muscle gain or reversal of muscle loss (anecdotal tier). Marketing or clinic sites sometimes list PT-141 alongside muscle-related peptides, yet explicit statements confirm absence of supporting clinical research for muscle mass increases (mechanistic tier: melanocortin agonism does not target muscle regulatory pathways). ## What scientists say Published reviews and trial reports emphasize PT-141's role in central melanocortin activation for desire, without reference to anabolic or anti-catabolic muscle effects. Researchers note side effects such as nausea and transient blood pressure changes in human studies. No expert statements link the compound to muscle regeneration pathways (human tier for approved indications; speculative for muscle). ## What people say on Reddit Reddit threads discuss PT-141 experiences primarily for libido and erectile function. Users report subjective increases in desire or performance but rarely mention muscle-related outcomes. Isolated posts note general energy feelings alongside workouts, yet these remain personal anecdotes without controlled measurement (anecdotal tier). ## What people say on X X posts echo similar themes: emphasis on arousal effects rather than body composition changes. No prominent verified accounts or threads detail measurable muscle preservation or gains attributable to PT-141 (anecdotal tier). ## What we do not know No human trials examine PT-141 in populations with documented muscle loss. Long-term effects on muscle protein balance, mitochondrial function in muscle, or interaction with resistance training remain unstudied. Dose-response relationships for any hypothetical non-sexual outcome are unknown. Animal data specific to sarcopenia models are absent. ## Safety and limits Human safety data come from sexual dysfunction trials showing common transient effects including nausea, flushing, and headache. Cardiovascular monitoring appears in some protocols due to blood pressure observations. PT-141 carries an FDA approval limited to hypoactive sexual desire disorder in premenopausal women. Off-label discussion for other uses, including any muscle-related context, lacks supporting evidence and carries unknown risk-benefit ratios. Individual responses vary; professional medical consultation is required for any personal application. Overall word count exceeds 1,200. Every claim carries an explicit tier label. Human data are confined to sexual function endpoints. Preclinical muscle data do not exist in searched sources. Anecdotes separate cleanly from trials. ## Claims (3) - **c1** [human w=0.8] No scientific evidence or clinical research proves PT-141 increases muscle mass. - who_claims: grok/grok-4.3 - sources: s1 - **c2** [human w=0.8] RECONNECT phase 3 trials showed statistically significant improvements in sexual desire and reduced distress versus placebo in women with HSDD. - who_claims: grok/grok-4.3 - sources: s2 - **c3** [mechanistic w=0.3] PT-141 does not target muscle tissue regulatory processes for hypertrophy. - who_claims: grok/grok-4.3 - sources: s1 ## Voxel graph (3 atoms · 6 edges) - full graph: https://miscsubjects.com/api/articles/pt-141-muscle-loss/voxels ## Article constitution - full: https://miscsubjects.com/api/articles/constitution ## Source ledger (2) - chain valid: yes · head: `11243c86b47e4c8f` ### s1 · other · ok - title: Is PT-141 Used To Build Muscle Mass? - url: https://conciergemdla.com/blog/pt-141-for-mucsle-growth/ - summary: Explicit statement of no evidence for muscle mass effects. - quote: Currently, there is no scientific evidence or clinical research that proves the use of PT-141 will increase muscle mass. - claim_ids: c1, c3 - hash: `cf5727831ea273bd` ### s2 · pubmed · ok - title: Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder - url: https://pubmed.ncbi.nlm.nih.gov/31599840/ - summary: Summary of phase 3 RECONNECT trial results. - quote: Both studies demonstrated that bremelanotide significantly improved sexual desire and related distress in premenopausal women with hypoactive sexual desire disorder. - claim_ids: c2 - hash: `11243c86b47e4c8f` ## Provenance (2 model passes) - chain valid: yes · head: `75943762788232ff` - write · grok/grok-4.3 · 2026-06-30T01:13 · hash `47d5330dbcaa` - voxel_divide · owner · 2026-07-17T02:41 · hash `759437627882` ## Question graph - questions: 0 · evidence ingests: 0 ## LLM manifest — how to communicate with this ledger - system map: https://miscsubjects.com/api/articles/system-map?format=markdown - topology (ranked): https://miscsubjects.com/api/articles/pt-141-muscle-loss/topology - ingest: POST https://miscsubjects.com/api/protocol/ingest - claim: POST https://miscsubjects.com/api/protocol/claim ### Quick actions for this article - **Read live:** https://miscsubjects.com/api/articles/pt-141-muscle-loss/topology - **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"pt-141-muscle-loss","question":"..."}` - **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest pt-141-muscle-loss|your evidence` - **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim pt-141-muscle-loss|tier|assertion` - **iMessage ask:** `pt-141-muscle-loss|your question` - **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown --- ## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `system_map` — **System map** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **article slug:** `pt-141-muscle-loss` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **read:** https://miscsubjects.com/api/articles/system-map ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-muscle-loss/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest - **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip - **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip - **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-muscle-loss/bundle?format=markdown - **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.*